DHDermatological Health3083-47752981-8206Bio-Byword Scientific Publishing Pty. Ltd.10.26689/dh.v3i1.9987ArticleReview of New Treatment Methods for Psoriasis and Dermatitishttps://artdesignp.com/journal/DH/3/1/10.26689/dh.v3i1.9987HanShaohua,ZhouTing,HuangFaqing2025312025-04-02Psoriasis and dermatitis are chronic and troubling skin diseases. To face this challenge, a variety of innovative therapeutic methods came into being. It is necessary to review and summarize the research process of these novel drug therapeutic methods. Local researchers have conducted a comprehensive understanding of the research of traditional medicines, and the research progress of novel therapeutic methods such as biologic drugs and small-molecule targeted drugs has been widely reported. A comprehensive comparison of the new treatments helps to reveal the nuances of each treatment and understand the depth and breadth of its therapeutic effects. New therapeutic approaches, such as cell transplantation, biologic drugs, and small-molecule targeted drugs, are more effective in the treatment of psoriasis and dermatitis than traditional approaches, with minimum side effects. The results of new drug research have opened new possibilities for the treatment of psoriasis and dermatitis, guided the path of future scientific research, and significantly improved the quality of life of patients.

Li M, Li W, 2019, Psoriatic Dermatitis: A New Disease? Chinese Journal of Dermatology and Venereology, 36(03): 362–366.

Liu J, Chen Y, Qian W, et al., 2019, Bimekizumab, a Novel Drug for the Treatment of Psoriasis. Journal of Clinical Pharmacotherapy, 19(09): 18–22.

Jiang J, Chen H, 2019, Biotherapy for Psoriasis in Children. Bulletin of Dermatology, 37(05): 496–502.

Yu C, Wang G, 2019, Small-Molecule Targeted Drugs: A New Option for the Treatment of Psoriasis. Chinese Journal of Dermatology, 55(09): 747–751.

Zhu W, Sun X, Hu X, 2019, Research Progress of Targeted Drugs for the Treatment of Psoriasis. Chinese Pharmacy, 30(04): 542–547.

Colonna C, Bortoluzzi P, Cavalli R, 2023, Dupilumab Treatment for Severe Atopic Dermatitis in Children and SARS-CoV2 Infection: A Combination of Triggers for Psoriasis. Journal of the European Academy of Dermatology and Venereology, 37(5): e568–e569.

Fahmy LM, Kwinta BD, Schreidah CM, et al., 2023, Topical Mechlorethamine for the Treatment of Psoriasis: A Report of Two Cases and Literature Review. Dermatology and therapy, 13(2): 617–627.

David E, Czarnowicki T, 2023, The Pathogenetic Role of Th17 Immune Response in Atopic Dermatitis. Current Opinion in Allergy and Clinical Immunology, 2023(5): 23.

Su Z, Zeng Y, Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review. Dermatology, 239(4): 646–657.

Fu XY, Lufei C, Liu X, et al., 2020, Compound for Treating Autoimmune Skin Diseases Caused by Inflammation, and Use Thereof, EP20200799197, EP3964212A1, viewed December 16, 2024.

Fujimoto R, Kataoka Y, 2022, Psoriasis-Like Eruptions Developed in an Atopic Dermatitis Patient Treated with Dupilumab. Journal of Cutaneous Immunology & Allergy, 5(6): 231–232.

Marko M, Pawliczak R, 2023, Resveratrol and Its Derivatives in Inflammatory Skin Disorders—Atopic Dermatitis and Psoriasis: A Review. Antioxidants, 12(11): 1954.

Dinish US, Yew YW, Vinod Ram K, et al., 2023, Non-Invasive Biochemical Analysis and Comparison of Atopic Dermatitis and Psoriasis Skin Using Handheld Confocal Raman Spectroscopy. Journal of Biophotonics, 16(12): e202300191.